TIL Therapy Amplifies the Immune System’s Attack on Melanoma
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
Progress Against Cancer
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
First CAR T-cell therapy approval in chronic lymphocytic leukemia, and Environmental Protection Agency announces a complete ban on asbestos...
Modified CAR T-cell therapy shows promise in glioblastoma, and an immunotherapy may soon be available as an injection.
Melanoma drug becomes first cell therapy approved to treat a solid tumor, and a new method for treating mesothelioma...
Researchers explore a try-everything approach to precision medicine, and physical activity may help ease cancer pain.
Patients and doctors urge researchers to study lower doses for cancer treatments, and the FDA faces criticism for not...
Improving fitness linked to lower prostate cancer risk, and a study from Scotland finds no cervical cancer cases in...
Study shines a light on the differences in outcomes between clinical trial patients with multiple myeloma and those receiving...
Questions about screening for women with dense breast tissue, and the FDA asks drugmakers to add a warning to...
Preventive gastrectomy has lasting effects, and rising cancer incidence undercuts continued progress against mortality.